Table 1.
Biomarker | Description | High-risk definition |
---|---|---|
Clinical cardiovascular and metabolic markers | ||
Systolic blood pressure | The maximum arterial blood pressure during each heartbeat. |
> 140 mmHG |
Diastolic blood pressure | The minimum arterial blood pressure during each heartbeat. |
> 90 mmHG |
Total cholesterol | A measure of cholesterol that includes low- density lipoprotein (LDL, or “bad” cholesterol) and high-density lipoprotein HDL, or “good” cholesterol). Excess cholesterol contributes to plaques in blood vessels. |
>= 240 mg/dL |
High-density lipoprotein (HDL) cholesterol | “Good” cholesterol; helps remove cholesterol from arteries. |
< 40 mg/dL |
Triglycerides | A lipid widespread in adipose tissue, circulates in the blood as lipoproteins. |
>= 200 mg/dL |
Glycosylated hemoglobin | A protein created when hemoglobin binds to glucose. A measure of blood glucose levels over the past several months. |
> 6.5% |
Insulin resistance | Estimated from the homeostatic model assessment (HOMA-IR). Derived from fasting blood glucose levels. |
Highest sex-specific quintile |
Body mass index (BMI) | Weight in kilograms / height in meters squared. A measure of body fat. |
> 30 or <18.5 |
Waist circumference | Waist circumference in centimeters. A marker of abdominal fat. |
> 102 cm for men > 88 cm for women |
Heart rate variability markers | ||
Mean heart rate | Mean heart rate over 24 hours (beats per minute). |
Highest sex-specific quintile |
Ratio of daytime to nighttime heart rate | Ratio of mean daytime heart rate (8:00 am – 8:00 pm) to mean nighttime heart rate (12:00 am - 4:00 am). |
Lowest sex-specific quintile |
Standard deviation of normal beat-to-beat intervals (SDNN) |
Standard deviation of all normal intervals over 24 hours. Measure of longer term variability. |
< 100 ms |
Root mean square of successive differences in normal beat-to-beat intervals (RMSSD) |
The square root of the mean of the squares of successive differences between adjacent normal heart beats. Measure of shorter term variability. |
Lowest sex-specific decile |
Inflammation markers | ||
C-reactive protein | Protein that is part of the inflammatory response. Increases in response to interleukin-6. |
> 3 mg/L |
Interleukin-6 | Inflammatory cytokine, promotes production of inflammatory proteins. |
Highest sex-specific quintile |
Fibrinogen | Protein that assists in blood clot formation. Increases as part of the inflammatory response. |
Highest sex-specific quintile |
Neuroendocrine markers | ||
Cortisol | Stress hormone produced by the adrenal gland. | Highest sex-specific quintile |
Dehydroepiandrosterone sulfate (DHEAS) | Steroid hormone produced by the adrenal gland. May counterbalance the effect of cortisol. |
Lowest sex-specific quintile |
Epinephrine | Hormone produced by the adrenal gland. Part of the fight-or-flight response. |
Highest or lowest sex-specific decile |
Norepinephrine | Hormone produced by the adrenal gland. Precursor to epinephrine. |
Highest sex-specific quintile |
Note: Each biomarker risk index represents a count of the number of biomarkers for which a participant falls in the high-risk category.